In this episode of ASTCT Talks, host Corey Cutler, MD of Dana-Farber Cancer Institute and Harvard University sits down with Nosha Farhadfar, MD, medical director of research for Sarah Cannon...

In this webinar, leading investigators and expert clinicians will discuss strategies for adopting GA in transplant clinical practices and identify areas for future research and quality...

Chimeric antigen receptor (CAR) T cells targeting B7-H3 show promise in treating diffuse intrinsic pontine glioma (DIPG), but researchers suspect the true potential of this approach will only be...

While an immunosuppressive tumor microenvironment (TME) limits the efficacy of chimeric antigen receptor (CAR) immunotherapy in solid tumors, lab experiments suggest the treatment could advance by...

New study results demonstrate CD19 chimeric antigen receptor (CAR) T-cell therapy as a promising therapeutic pathway for autoimmune hemolytic anemia (AIHA), which is notoriously prone to...

Scientists report encouraging results from a clinical trial of VCAR33, a chimeric antigen receptor (CAR) T-cell construct designed to curtail acute myeloid leukemia (AML) or myelodysplastic...